INFU:NYE-InfuSystems Holdings Inc (USD)

COMMON STOCK | Medical Instruments & Supplies |

Last Closing

USD 8.12

Change

0.00 (0.00)%

Market Cap

USD 0.17B

Volume

0.03M

Analyst Target

USD 24.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-27 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
BDX Becton Dickinson and Company

N/A

USD 68.11B
ALC Alcon AG

N/A

USD 40.45B
HYB New America High Income Closed..

N/A

USD 35.93B
RMD ResMed Inc

N/A

USD 31.27B
WST West Pharmaceutical Services I..

N/A

USD 27.24B
BAX Baxter International Inc

N/A

USD 18.19B
ATR AptarGroup Inc

N/A

USD 9.84B
TFX Teleflex Incorporated

N/A

USD 9.61B
STVN Stevanato Group SpA

N/A

USD 7.29B
BLCO Bausch + Lomb Corp

N/A

USD 5.42B

ETFs Containing INFU

FTXR First Trust Nasdaq Transp.. 7.93 % 0.60 %

N/A

USD 0.04B
WBIY WBI Power Factor® High D.. 4.90 % 0.70 %

N/A

USD 0.06B
RDIV Invesco S&P Ultra Dividen.. 4.81 % 0.39 %

N/A

USD 0.74B
RPV Invesco S&P 500® Pure Va.. 2.74 % 0.35 %

N/A

USD 2.02B
ZVU:CA BMO MSCI USA Value ETF 2.31 % 0.33 %

N/A

CAD 0.04B
DVYL 2.17 % 0.00 %

N/A

N/A
SPDV AAM S&P 500 High Dividend.. 2.08 % 0.29 %

N/A

USD 0.06B
SPYD SPDR® Portfolio S&P 500 .. 1.40 % 0.08 %

N/A

USD 6.65B
IMCV iShares Morningstar Mid-C.. 0.99 % 0.00 %

N/A

USD 0.59B
JKI iShares Morningstar Mid-C.. 0.97 % 0.30 %

N/A

USD 0.60B
RCD 0.00 % 0.40 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -22.96% 6% D- 6% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return -22.96% 6% D- 6% D-
Trailing 12 Months  
Capital Gain -13.34% 39% F 16% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -13.34% 39% F 14% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 21.40% 78% C+ 85% B
Dividend Return 21.40% 78% C+ 84% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 65.43% 28% F 13% F
Risk Adjusted Return 32.71% 72% C 55% F
Market Capitalization 0.17B 22% F 31% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.